about
Profile of verteporfin and its potential for the treatment of central serous chorioretinopathyAdvances in the treatment of central serous chorioretinopathyComment on "Short-term effects of relaxation music on patients suffering from primary open-angle glaucoma".Incidence and natural course of symptomatic central serous chorioretinopathy in pregnant women in a maternity hospital in Kuwait.Subthreshold diode laser micropulse photocoagulation versus intravitreal injections of bevacizumab in the treatment of central serous chorioretinopathySerum cortisol and testosterone levels in idiopathic central serous chorioretinopathy.Cadherin 5 is regulated by corticosteroids and associated with central serous chorioretinopathyHelicobacter pylori infection and eye diseases: a systematic review.Central serous chorioretinopathy: update on pathophysiology and treatment.Clinical characteristics of responders to intravitreal bevacizumab in central serous chorioretinopathy patients.Comparison of Serum Cortisol and Testosterone Levels in Acute and Chronic Central Serous ChorioretinopathyBilateral simultaneous central serous chorioretinopathy in a teenage girl with systemic arterial hypertension.Diffuse retinal pigment epitheliopathy complicating systemic corticosteroid treatment.Personality and uveitis.Subfoveal Choroidal Thickness in Central Serous Chorioretinopathy: A Meta-Analysis.En face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathyEffects of photodynamic therapy with verteporfin for the treatment of chronic central serous chorioretinopathy: An uncontrolled, open-label, observational studyDiagnosed a Patient with Central Serous Chorioretinopathy? Now What?: Management of Central Serous Chorioretinopathy.Long-term prognostic factors of chronic central serous chorioretinopathy after half-dose photodynamic therapy: A 3-year follow-up study.Shallow Anterior Chamber in a Severe Case of Unilateral Acute Central Serous Retinal Detachment.Photoreceptor disruption in central serous chorioretinopathy treated by half-dose photodynamic therapyCONCURRENT IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2 AND CENTRAL SEROUS CHORIORETINOPATHY.Association between endogenous cortisol level and the risk of central serous chorioretinopathy: a Meta-analysis.Cushing's Syndrome and Hypothalamic-Pituitary-Adrenal Axis Hyperactivity in Chronic Central Serous Chorioretinopathy.Combined Argon Laser and Low Dose Acetylsalicylic acid in Treatment of Acute Central Serous Chorioretinopathy
P2860
Q26824756-9687136E-6A18-4516-A2B8-49D859A45B57Q28088443-8E67D0F0-DE6A-4D44-BA79-CB89D8FFA81AQ30383011-71417F70-8780-4BF1-9F93-41FA6F101EC3Q30465497-F786A090-E519-4E30-A55E-5C28930CE8BFQ31040895-38841B4B-E61B-40A9-8DCE-7847E54EAE6EQ33616095-05FF4A47-143F-4962-AD14-9AE9E5109F08Q34434358-757051E5-088E-43CB-AE30-898E4A263088Q34454857-1FD5C13D-C42B-459F-AC54-0B7071415BC4Q34587658-C62355B8-AB89-47C4-9830-CDC2D5658131Q35749002-54281CA5-6863-433C-9AA5-F979D0317F24Q36342988-BFB51795-ECE7-4594-99B6-07ED38363C9EQ36508224-385E9B43-2D3D-450E-BB74-D3DD320C772DQ37315793-5258227B-1F1B-4F6C-B900-2C0BBA74CCECQ37318003-F0B1CCBF-F3F6-4B5C-8BC3-6DB521236BF6Q37580515-63626C55-4D60-4373-83E5-642AC05A9FD0Q37619588-E1CCB838-17C2-4420-AC7C-8E22FB530680Q37667426-55F1BFC9-B51A-47CA-B0A5-ECF7C11CE7D7Q38644045-613F04EA-CE89-4048-998E-B9CEE924A3B9Q41106280-B21D37C6-EC2A-4462-BDE8-0369F5B938EBQ42195454-00C103FE-799F-4B8D-9796-0B2E0A5E6D3CQ42237072-F68375C8-3BE3-4968-84D0-C194FE9ABE63Q50088688-3D8B1302-9B89-45AA-8D69-C2EE92F21F40Q50315291-F0CDEC46-69DF-488F-B736-2019BE2BA3CBQ55221824-47413424-D3FF-4FF9-A462-53A8355DAB1AQ58597189-1906957C-EBE8-49A5-9BF3-02EB56F60805
P2860
description
1986 nî lūn-bûn
@nan
1986 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
name
Type A behavior and central serous chorioretinopathy.
@ast
Type A behavior and central serous chorioretinopathy.
@en
Type A behavior and central serous chorioretinopathy.
@nl
type
label
Type A behavior and central serous chorioretinopathy.
@ast
Type A behavior and central serous chorioretinopathy.
@en
Type A behavior and central serous chorioretinopathy.
@nl
prefLabel
Type A behavior and central serous chorioretinopathy.
@ast
Type A behavior and central serous chorioretinopathy.
@en
Type A behavior and central serous chorioretinopathy.
@nl
P2860
P1476
Type A behavior and central serous chorioretinopathy.
@en
P2093
Yannuzzi LA
P2860
P304
P577
1986-01-01T00:00:00Z